Therapeutics targeting IL-13 for the treatment of pulmonary inflammation and airway remodeling
{{output}}
Targeting the IL-13 pathway appears to be a viable approach to ameliorate pulmonary inflammation and remodeling. Support for this hypothesis comes from preclinical and preliminary clinical data. Diverse approaches have been used to target the IL-13 pathway, in... ...
